コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 typical for the cap-binding protein known as eukaryotic initiation factor 4E.
2 phorylation of translation initiation factor eukaryotic initiation factor 4E.
3 osphorylate physiological substrates such as eukaryotic initiation factor 4E.
4 slation by targeting the cap-binding protein eukaryotic initiation factor 4E, a key regulator of cell
6 Finally, IL-1beta enhanced the expression of eukaryotic initiation factor 4E, a stimulator of LIP exp
7 irways have increased phosphorylation of the eukaryotic initiation factor 4E and its partner the 4E-b
8 tiation factor 4E-binding protein 1 (4E-BP1)/eukaryotic initiation factor 4E and ribosomal p70 S6 kin
9 nt formation of a functional complex between eukaryotic initiation factor-4E and eukaryotic initiatio
10 ts in sequential dissociation of 4E-BP1 from eukaryotic initiation factor-4E and subsequent formation
11 phorylates the translation initiation factor eukaryotic initiation factor-4E and triggers antiapoptot
12 tion factor-4E-binding proteins 1 and 2, and eukaryotic initiation factor-4E, are present in the rat
15 ly depends on transcriptional enhancement of eukaryotic initiation factor 4E binding protein (4E-BP)
16 orylation of two downstream targets of mTOR, eukaryotic initiation factor 4E binding protein 1 (4E-BP
17 Furthermore, Rheb induces phosphorylation of eukaryotic initiation factor 4E binding protein 1 (4E-BP
18 tion of p70 ribosomal S6 kinase (p70s6K) and eukaryotic initiation factor 4E binding protein 1 (4EBP1
19 Thr-308 and Ser-473), S6 kinase 1 (Thr-389), eukaryotic initiation factor 4E binding protein 1 (Thr-3
20 his stress response depends on expression of eukaryotic initiation factor 4E binding protein 1 and is
21 p70 ribosomal protein S6 kinase 1 [S6K1] and eukaryotic initiation factor 4E binding protein 1) and c
22 phosphorylation of pH acid stable protein I (eukaryotic initiation factor 4E binding protein) were ex
23 rylation of both the translational repressor eukaryotic initiation factor 4E binding protein-1 and p7
24 protein synthesis by inhibition of eIF4EBPs (eukaryotic Initiation Factor 4E Binding Proteins), regul
25 p70 ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding (eIF4E-binding)
26 C1) activation as indicated by a decrease in eukaryotic initiation factor 4E-binding 1 (4E-BP1) phosp
27 through mTOR resulting in phosphorylation of eukaryotic initiation factor 4E-binding protein (4E-BP)1
28 mTORC1 signaling through p70S6Ks (S6K1/2) or eukaryotic initiation factor 4E-binding protein (4E-BP1/
29 , and mLST8, is activated and phosphorylates eukaryotic initiation factor 4E-binding protein (4EBP) a
30 ence of amino acids increased the binding of eukaryotic initiation factor 4E-binding protein (4EBP1)
31 ever, adult HSCs had more hypophosphorylated eukaryotic initiation factor 4E-binding protein 1 (4E-BP
32 et of rapamycin (mTOR)-mediated signaling to eukaryotic initiation factor 4E-binding protein 1 (4E-BP
33 translation through two downstream pathways: eukaryotic initiation factor 4E-binding protein 1 (4E-BP
34 wo translation modulators, p70 S6 kinase and eukaryotic initiation factor 4E-binding protein 1 (4E-BP
35 Phosphorylation of the translation repressor eukaryotic initiation factor 4E-binding protein 1 (4E-BP
39 d induced the phosphorylation of p70S6K1 and eukaryotic initiation factor 4E-binding protein 1 (4E-BP
40 , eukaryotic elongation factor 2 (eEF2), and eukaryotic initiation factor 4E-binding protein 1 (4E-BP
41 active mutant of the translational repressor eukaryotic initiation factor 4E-binding protein 1 (4E-BP
42 mTOR)/p70 ribosomal protein S6 kinase (S6K1)/eukaryotic initiation factor 4E-binding protein 1 (4E-BP
43 This effect was dependent on expression of eukaryotic initiation factor 4E-binding protein 1 (4E-BP
44 g the downstream translational repression of eukaryotic initiation factor 4E-binding protein 1 (4E-BP
45 rget of rapamycin to its downstream targets: eukaryotic initiation factor 4E-binding protein 1 (4E-BP
46 athways of p70 ribosomal S6 kinase (p70S6K), eukaryotic initiation factor 4E-binding protein 1 (4EBP1
47 rEC showed selective increased expression of eukaryotic initiation factor 4E-binding protein 1 (4EBP1
48 these hearts restored 70-kDa S6 kinase 1 and eukaryotic initiation factor 4E-binding protein 1 phosph
49 , reductions in Akt, 70-kDa S6 kinase 1, and eukaryotic initiation factor 4E-binding protein 1 phosph
50 ation of the translational regulators 4E-BP1(eukaryotic initiation factor 4E-binding protein 1) and p
52 on of the negative regulator of translation, eukaryotic initiation factor 4E-binding protein 1, and i
53 d completely suppressed Akt, GSK3beta, mTOR, eukaryotic initiation factor 4E-binding protein 1, and S
54 n of the ribosomal protein S6 kinase and the eukaryotic initiation factor 4E-binding protein 1, two d
55 activity of p70(s6k) and phosphorylation of eukaryotic initiation factor 4E-binding protein 1, were
56 ng to the phosphorylation of S6 kinase 1 and eukaryotic initiation factor 4E-binding protein 1, which
59 ng protein interacting protein 2 (Paip2) and eukaryotic initiation factor 4E-binding protein 2 (4E-BP
60 egulator of mRNA translation initiation, the eukaryotic initiation factor 4E-binding protein 2, leads
61 dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the
62 4EBP1 (properties of heat and acid stability/eukaryotic initiation factor 4E-binding protein) and aut
63 d in part through the phosphorylation of the eukaryotic initiation factor 4E-binding protein, PHAS-I.
64 n S6 kinase (p70s6k) and the function of the eukaryotic initiation factor 4E-binding protein-1 (4E-BP
65 ncrease in ribosomal protein S6 kinase 1 and eukaryotic initiation factor 4E-binding protein-1 (4E-BP
66 R signaling phosphoproteins, including mTOR, eukaryotic initiation factor 4E-binding protein-1, p70S6
67 phorylation of ribosomal S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein-1, two k
69 ned the expression and distribution of mTOR, eukaryotic initiation factor 4E-binding protein1/2 (4E-B
70 via the phosphorylation and inactivation of eukaryotic initiation factor 4E-binding proteins (4E-BPs
71 is controlled by the translation inhibitors, Eukaryotic initiation factor 4E-binding proteins (4E-BPs
72 se include translational repressor proteins (eukaryotic initiation factor 4E-binding proteins, 4E-BPs
73 esion kinase, mammalian target of rapamycin, eukaryotic initiation factor-4E-binding protein-1, and r
74 slational signaling pathway, including mTOR, eukaryotic initiation factor-4E-binding proteins 1 and 2
75 of translation p70S6 kinase (S6K) and of the eukaryotic initiation factor 4E-BP1 binding protein (4E-
77 prehensively capture and quantify the eIF4E (eukaryotic initiation factor 4E) 'cap-ome' and apply it
78 d mRNAs is inhibited by dephosphorylation of eukaryotic initiation factor 4E (eIF-4E) (cap-binding pr
79 tion of the translation initiation proteins, eukaryotic initiation factor 4E (eIF-4E) and 4E-binding
80 In BAEC, TNF promotes phosphorylation of eukaryotic initiation factor 4E (eIF-4E), c-Jun N-termin
82 ascade leading to the phosphorylation of the eukaryotic initiation factor-4E (eIF-4E) binding protein
84 IF4E-binding protein 1 (4E-BP1) binds to the eukaryotic initiation factor-4E (eIF-4E), preventing for
86 (eIF2alpha Ser51; -20 +/- 5%, P < 0.05) and eukaryotic initiation factor 4E (eIF4E Ser209; +33 +/- 1
87 endent translation by forming a complex with eukaryotic initiation factor 4E (eIF4E) (eIF4E*4E-BP1).
90 programs that are sensitive to depletion of eukaryotic initiation factor 4E (eIF4E) and phosphorylat
91 For instance, the interaction between the eukaryotic initiation factor 4E (eIF4E) and viral protei
92 proliferation via the translation regulators eukaryotic initiation factor 4E (eIF4E) binding protein
93 ranslation in part by phosphorylation of the eukaryotic initiation factor 4E (eIF4E) binding protein
94 a mediates induction of VEGF expression in a eukaryotic initiation factor 4E (eIF4E) binding protein
95 hosphorylation of p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein
96 s not mediated by reduced phosphorylation of eukaryotic initiation factor 4E (eIF4E) binding protein
98 nases 1 and 2 (S6K1/2) and inhibition of the eukaryotic initiation factor 4E (eIF4E) binding proteins
99 ing pathways enhanced polysome occupancy and eukaryotic initiation factor 4E (eIF4E) binding to the 5
111 h, in turn, regulates phosphorylation of the eukaryotic initiation factor 4E (eIF4E) on Ser-209.
112 ective of this study is to determine if high eukaryotic initiation factor 4E (eIF4E) overexpression (
118 tein kinase interacting kinases 1/2 (MNK1/2)-eukaryotic initiation factor 4E (eIF4E) signaling axis p
119 ) resulted in redistribution of the critical eukaryotic initiation factor 4E (eIF4E) to an mRNA granu
121 in translation initiation is the binding of eukaryotic initiation factor 4E (eIF4E) to the 5' mRNA c
122 tiation of translation is the binding of the eukaryotic initiation factor 4E (eIF4E) to the cap struc
124 te the phosphorylation and activation of the eukaryotic initiation factor 4E (eIF4E), a protein that
125 h biotin and an orthosteric inhibitor of the eukaryotic initiation factor 4E (eIF4E), an enzyme invol
126 of Pea enation mosaic virus (PEMV) binds to eukaryotic initiation factor 4E (eIF4E), but how this af
127 machinery, SFV reduces levels of translation eukaryotic initiation factor 4E (eIF4E), diminishes phos
128 interaction among initiation factors such as eukaryotic initiation factor 4E (eIF4E), eIF4A, and eIF4
129 tional function of SLBP genetically required eukaryotic initiation factor 4E (eIF4E), eIF4G, and eIF3
130 importance is the complex between cap-bound eukaryotic initiation factor 4E (eIF4E), eIF4G, and poly
131 n of 4E-BP1, a repressor binding protein for eukaryotic initiation factor 4E (eIF4E), that was depend
133 of PHAS-I with the mRNA cap-binding protein, eukaryotic initiation factor 4E (eIF4E), were investigat
135 egulates the p70S6 kinase (p70(S6k)) and the eukaryotic initiation factor 4E (eIF4E)-binding protein
136 (CDK1/CYCB1) to directly hyperphosphorylate eukaryotic initiation factor 4E (eIF4E)-binding protein
139 ression of constitutively hypophosphorylated eukaryotic initiation factor 4E (eIF4E)-binding protein
142 /3 (4EBP), which inhibits the translation of eukaryotic initiation factor 4E (eiF4E)-bound mRNAs.
143 ian capped mRNAs is achieved through the cap-eukaryotic initiation factor 4E (eIF4E)-eIF4G-eIF3-40S c
144 major product in a subtraction library from eukaryotic initiation factor 4E (eIF4E)-transformed cell
151 3 kinase or blocking the interaction between eukaryotic initiation factors 4E (eIF4E) and 4G (eIF4G)
153 associated with increased phosphorylation of eukaryotic initiation factor 4E (elF-4E) and the transla
155 NFAT, and translation factors, specifically eukaryotic initiation factor 4E (elf4E) and S6 ribosomal
156 AS-I in sites that control PHAS-I binding to eukaryotic initiation factor 4E; however, whether mTOR d
157 (mTOR), and it prevents the dissociation of eukaryotic initiation factor 4E protein (eIF4E) from 4E-
158 E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil,
160 e channel itself, releasing both from eIF4E (eukaryotic initiation factor 4E), where they normally in